Nucleic acid amplification tests for diagnosis of Bordetella infections

被引:123
作者
Riffelmann, M
von König, CHW
Caro, V
Guiso, N
机构
[1] Inst Infektiol Krefeld GmbH, D-47805 Krefeld, Germany
[2] Inst Pasteur, Paris, France
关键词
D O I
10.1128/JCM.43.10.4925-4929.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The global epidemiology of pertussis has recently been reviewed (12, 15). Bordetella pertussis continues to circulate even in populations where high vaccination coverage of infants and children is achieved (15, 23), because the protection after natural infection wanes after 10 to 15 years and protection after vaccination lasts for 6 to 10 years (15). A significant increase of pertussis cases was observed in the United States, in Europe, and in other countries with high vaccination coverage, making pertussis a reemerging disease. Transmission of the disease in highly vaccinated populations occurs mainly from adolescents and adults to infants or among older vaccinated children, adolescents, and adults (15). Thus, most cases of pertussis are now observed in unvaccinated infants, older schoolchildren, adolescents, and adults. In outbreak situations asymptomatic carriage has been observed in up to similar to 50% (12).
引用
收藏
页码:4925 / 4929
页数:5
相关论文
共 24 条
  • [1] Comparison of real-time PCR and conventional hemi-nested PCR for the detection of Bordetella pertussis in nasopharyngeal samples
    Anderson, TP
    Beynon, KA
    Murdoch, DR
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 746 - 749
  • [2] Impact of nasopharyngeal swab types on detection of Bordetella pertussis by PCR and culture
    Cloud, JL
    Hymas, W
    Carroll, KC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3838 - 3840
  • [3] Description of a multiplex Bordetella pertussis and Bordetella parapertussis LightCycler® PCR assay with inhibition control
    Cloud, JL
    Hymas, WC
    Turlak, A
    Croft, A
    Reischl, U
    Daly, JA
    Carroll, KC
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (03) : 189 - 195
  • [4] COCKERILL FR, 2003, Patent No. 20030165866
  • [5] Laboratory diagnosis of pertussis infections: the role of PCR and serology
    Fry, NK
    Tzivra, O
    Li, YT
    McNiff, A
    Doshi, N
    Maple, PAC
    Crowcroft, NS
    Miller, E
    George, RC
    Harrison, TG
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (06) : 519 - 525
  • [6] Fry NK, 2004, CLIN MICROBIOL INFEC, V10, P7
  • [7] COMPARISON OF NASOPHARYNGEAL ASPIRATES WITH SWABS FOR CULTURE OF BORDETELLA-PERTUSSIS
    HALLANDER, HO
    REIZENSTEIN, E
    RENEMAR, B
    RASMUSON, G
    MARDIN, L
    OLIN, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (01) : 50 - 52
  • [8] Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences
    He, QS
    SchmidtSchlapfer, G
    Just, M
    Matter, HC
    Nikkari, S
    Viljanen, MK
    Mertsola, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) : 1288 - 1295
  • [9] Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis
    Kösters, K
    Reischl, U
    Schmetz, J
    Riffelmann, M
    von König, CHW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) : 1719 - 1722
  • [10] Kösters K, 2001, J MED MICROBIOL, V50, P436, DOI 10.1099/0022-1317-50-5-436